The Cooper Companies(US:COO) ZACKS·2025-12-05 00:31Core Insights - The Cooper Companies reported revenue of $1.07 billion for the quarter ended October 2025, reflecting a year-over-year increase of 4.6% and an EPS of $1.15, up from $1.04 in the same quarter last year [1] - The revenue exceeded the Zacks Consensus Estimate of $1.06 billion, resulting in a surprise of +0.45%, while the EPS also surpassed expectations by +3.6% [1] Financial Performance - Revenue by Geography: - Americas: $285.1 million, a +5.4% change year-over-year, but below the estimated $291.49 million [4] - Asia Pacific: $147.4 million, a -1.3% change year-over-year, exceeding the estimated $139.8 million [4] - EMEA: $277.1 million, an +8% change year-over-year, above the estimated $269.49 million [4] - Revenue by Category: - CVI: $709.6 million, a +4.9% change year-over-year, slightly above the estimated $707.83 million [4] - CSI: $355 million, a +3.8% change year-over-year, exceeding the estimated $352.65 million [4] - CSI- Office and surgical: $214.6 million, a +5.8% change year-over-year, above the estimated $208.89 million [4] - CSI- Fertility: $141 million, a +1.3% change year-over-year, below the estimated $144.03 million [4] - CVI- Sphere, other: $365 million, a +3.3% change year-over-year, above the estimated $362.34 million [4] - CVI- Toric and multifocal: $344.6 million, a +6.6% change year-over-year, slightly below the estimated $346.45 million [4] Stock Performance - The Cooper Companies' shares have returned +10.3% over the past month, significantly outperforming the Zacks S&P 500 composite, which changed by +0.1% [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance in the near term [3]